Efficacy of 50% Oral Dextrose As Pain Relief in Newborns Before Bladder Catheterization
1 other identifier
interventional
90
1 country
1
Brief Summary
The aim of this study is to determine the effect of 50% oral dextrose in reducing pain before Bladder Catheterization. This study will answer the following question Is there any effect of 50% dextrose in reducing pain response to infants from age 1-90 days undergoing bladder catheterization during their visit in emergency department it is double blind randomized control trial comparing 2ml 50% dextrose as oral solution with placebo 2ml of normal water Primary Objective \- To evaluate the impact of administrating oral glucose on pain control compared with placebo in blood pressure , Heart rate, respiratory rate and oxygen saturation before and after the procedure Secondary Objectives
- To compare random blood sugar before and after the procedure
- To compare the incident and the duration of crying in both groups administration of oral solution 2ml of solutions to be administered orally as drops at tip of the tongue after that will wait for 2 minutes before the procedure start , after 2 minutes from the oral solution , the procedure will start
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2024
CompletedStudy Start
First participant enrolled
October 9, 2024
CompletedFirst Posted
Study publicly available on registry
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedOctober 10, 2024
October 1, 2024
5 months
October 3, 2024
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
change in blood pressure
blood pressure will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline blood pressure will be compared with the blood pressure during procedure after oral solution) the different of both blood pressure will be analyzed whiter there is significant change or not in both group
3 minutes, 5 minutes and 7 minutes after oral solution will be administrated
change in The Neonatal Infant Pain Scale (NIPS)
the Neonatal Infant Pain Scale (NIPS) will be calculated by trained treating nurse staff 3 minutes, 5 minutes and 7 minutes after administration of oral solution
3 minutes, 5 minutes and 7 minutes after administration of oral solution
change in the heart rate
heart rate will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline heart rate will be compared with the heart rate during procedure after oral solution) the different of both heart rate will be analyzed whiter there is significant change or not in both group
3 minutes, 5 minutes and 7 minutes after oral solution administration.
change in respiratory rate
respiratory rate will be measured before the procedure and 3 minutes, 5 minutes and 7 minutes after oral solution administration. each vital will be analyzed as single variable comparing it with the baseline. for example (baseline respiratory rate will be compared with the respiratory rate during procedure after oral solution) the different of both heart rate will be analyzed whiter there is significant change or not in both group
3 minutes, 5 minutes and 7 minutes after oral solution administration.
Secondary Outcomes (3)
random blood sugar
10 minutes
the duration of crying in placebo group
10 minutes
the duration of crying in dextrose group
10 minutes
Study Arms (2)
control group
PLACEBO COMPARATORin this arm participant will receive oral 2ml of normal water
50% dextrose group
EXPERIMENTALthis arm will include the participant who will receive 50% oral dextrose
Interventions
Eligibility Criteria
You may qualify if:
- Age from 1 day to 90 days
- Did not received analgesia for last 6 hours
You may not qualify if:
- Preterm newborns presenting in ED younger than 38 weeks (corrected age)
- Unstable child
- Suspicion of enterocolitis
- Esophageal- tracheal fistula not operated
- Known case of fructose intolerance
- Oral congenital malformation (cleft palate)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ali Al Qubtan
Muscat, Muḩāfaz̧at Masqaţ, 100, Oman
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Randomization will be generated at the local pharmacy by a computer program in blocks of two and the randomization allotment only will be known by a pharmacist not involved in the care of the children. after that the pharmacist will prepper the syringe than contain the 2ml 50% dextrose or the placebo 2ml normal water. each syringe will have code. the code key will be only with the pharmacist.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- emergency resident
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 10, 2024
Study Start
October 9, 2024
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
October 10, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis
- Access Criteria
- Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).
Data obtained through this study may be provided to qualified researchers with academic interest in randomized control trials. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.